electroCore, Inc.(ECOR) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

electroCore, Inc. is a commercial stage medical device company, which engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. The company is headquartered in Basking Ridge, New Jersey and currently employs 91 full-time employees. The firm is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and respiratory fields. The firm's gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy, which stimulates the cervical branch of the vagus nerve. The gammaCore is a non-drug treatment for adults who suffer from episodic cluster and migraine pain. The firm's target is the treatment of primary headaches (migraine and cluster headache), and the associated chronic co-morbidities of gastric motility, psychiatric, sleep and pain disorders.

Current Price

$1.62

RSI

36.447

May 22, 2020
1.4M
-3.1M

38.012 %
11.811 %
25.431 %
32.470 %

$3,495,491
$2,390,279
$992,953
46.238 %
140.724 %

$-24,681,940
$-45,130,184
$-55,818,029
45.309 %
19.148 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.